Brown Brothers Harriman & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $96.2M | Sell |
191,956
-146,663
| -43% | -$70.4M | 0.42% | 47 |
|
|
2026
Q1 | $166M | Sell |
338,619
-121,341
| -26% | -$65.9M | 0.89% | 29 |
|
|
2025
Q4 | $267M | Sell |
459,960
-56,425
| -11% | -$31.9M | 1.45% | 19 |
|
|
2025
Q3 | $250M | Sell |
516,385
-6,201
| -1% | -$2.89M | 1.53% | 17 |
|
|
2025
Q2 | $212M | Sell |
522,586
-671
| -0.1% | -$281K | 1.36% | 23 |
|
|
2025
Q1 | $260M | Sell |
523,257
-6,237
| -1% | -$3.38M | 1.82% | 19 |
|
|
2024
Q4 | $275M | Sell |
529,494
-10,874
| -2% | -$5.98M | 1.93% | 19 |
|
|
2024
Q3 | $334M | Sell |
540,368
-4,726
| -0.9% | -$2.8M | 2.27% | 17 |
|
|
2024
Q2 | $301M | Sell |
545,094
-8,264
| -1% | -$4.73M | 2.27% | 17 |
|
|
2024
Q1 | $322M | Sell |
553,358
-5,948
| -1% | -$3.34M | 2.47% | 14 |
|
|
2023
Q4 | $297M | Sell |
559,306
-13,728
| -2% | -$6.64M | 2.47% | 15 |
|
|
2023
Q3 | $290M | Sell |
573,034
-9,401
| -2% | -$5.01M | 2.56% | 14 |
|
|
2023
Q2 | $304M | Buy |
582,435
+24,733
| +4% | +$13.3M | 2.45% | 14 |
|
|
2023
Q1 | $321M | Sell |
557,702
-11,301
| -2% | -$6.37M | 2.69% | 12 |
|
|
2022
Q4 | $313M | Sell |
569,003
-11,846
| -2% | -$6.28M | 2.74% | 11 |
|
|
2022
Q3 | $295M | Buy |
580,849
+12,614
| +2% | +$7.06M | 2.73% | 11 |
|
|
2022
Q2 | $309M | Buy |
568,235
+31,737
| +6% | +$17.5M | 2.64% | 13 |
|
|
2022
Q1 | $317M | Buy |
536,498
+10,530
| +2% | +$6.05M | 2.24% | 15 |
|
|
2021
Q4 | $351K | Sell |
525,968
-4,345
| -0.8% | -$2.71M | 1.97% | 14 |
|
|
2021
Q3 | $303K | Sell |
530,313
-11,384
| -2% | -$6.25M | 1.79% | 17 |
|
|
2021
Q2 | $273K | Sell |
541,697
-482
| -0.1% | -$227K | 1.61% | 22 |
|
|
2021
Q1 | $247K | Buy |
542,179
+82,981
| +18% | +$39.6M | 1.58% | 25 |
|
|
2020
Q4 | $214M | Sell |
459,198
-7,182
| -2% | -$3.37M | 1.43% | 31 |
|
|
2020
Q3 | $206M | Buy |
466,380
+457,783
| +5,325% | +$189M | 1.48% | 27 |
|
|
2020
Q2 | $3.12M | Buy |
8,597
+227
| +3% | +$76.1K | 0.02% | 122 |
|
|
2020
Q1 | $2.37M | Sell |
8,370
-501
| -6% | -$158K | 0.02% | 135 |
|
|
2019
Q4 | $2.88M | Sell |
8,871
-166
| -2% | -$50.3K | 0.02% | 147 |
|
|
2019
Q3 | $2.63M | Buy |
9,037
+93
| +1% | +$26.6K | 0.02% | 143 |
|
|
2019
Q2 | $2.63M | Buy |
8,944
+109
| +1% | +$30K | 0.02% | 142 |
|
|
2019
Q1 | $2.42M | Buy |
8,835
+2,228
| +34% | +$554K | 0.02% | 141 |
|
|
2018
Q4 | $1.48M | Sell |
6,607
-577
| -8% | -$135K | 0.01% | 165 |
|
|
2018
Q3 | $1.75M | Sell |
7,184
-555
| -7% | -$128K | 0.01% | 156 |
|
|
2018
Q2 | $1.6M | Sell |
7,739
-286
| -4% | -$60.7K | 0.01% | 148 |
|
|
2018
Q1 | $1.66M | Sell |
8,025
-1,195
| -13% | -$251K | 0.01% | 145 |
|
|
2017
Q4 | $1.75M | Sell |
9,220
-588
| -6% | -$113K | 0.01% | 147 |
|
|
2017
Q3 | $1.86M | Sell |
9,808
-229
| -2% | -$41.5K | 0.01% | 138 |
|
|
2017
Q2 | $1.75M | Buy |
10,037
+445
| +5% | +$74.7K | 0.01% | 138 |
|
|
2017
Q1 | $1.47M | Buy |
9,592
+703
| +8% | +$107K | 0.01% | 145 |
|
|
2016
Q4 | $1.25M | Sell |
8,889
-338
| -4% | -$49.8K | 0.01% | 153 |
|
|
2016
Q3 | $1.47M | Sell |
9,227
-1,928
| -17% | -$297K | 0.01% | 153 |
|
|
2016
Q2 | $1.65M | Sell |
11,155
-190
| -2% | -$28K | 0.01% | 151 |
|
|
2016
Q1 | $1.61M | Buy |
11,345
+3,583
| +46% | +$480K | 0.01% | 153 |
|
|
2015
Q4 | $1.1M | Sell |
7,762
-1,096
| -12% | -$146K | 0.01% | 185 |
|
|
2015
Q3 | $1.08M | Buy |
8,858
+271
| +3% | +$35.3K | 0.01% | 182 |
|
|
2015
Q2 | $1.11M | Sell |
8,587
-2,031
| -19% | -$265K | 0.01% | 181 |
|
|
2015
Q1 | $1.43M | Sell |
10,618
-248
| -2% | -$32K | 0.01% | 172 |
|
|
2014
Q4 | $1.36M | Buy |
10,866
+281
| +3% | +$34.2K | 0.01% | 175 |
|
|
2014
Q3 | $1.29M | Hold |
10,585
| – | – | 0.01% | 182 |
|
|
2014
Q2 | $1.25M | Sell |
10,585
-4,600
| -30% | -$541K | 0.01% | 192 |
|
|
2014
Q1 | $1.83M | Buy |
15,185
+4,640
| +44% | +$552K | 0.01% | 153 |
|
|
2013
Q4 | $1.17M | Buy |
10,545
+5,095
| +93% | +$507K | 0.01% | 178 |
|
|
2013
Q3 | $502K | Buy |
5,450
+1,198
| +28% | +$108K | ﹤0.01% | 235 |
|
|
2013
Q2 | $360K | Buy |
+4,252
| New | +$354K | ﹤0.01% | 324 |
|
Other funds holding TMO
Brown Brothers Harriman & Co's TMO Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its Thermo Fisher Scientific (TMO) stake by 43% in Q2 2026, selling an estimated $70.4M and leaving 191,956 shares worth $96.2M. The position accounts for 0.42% of the portfolio, ranked #47.
Brown Brothers Harriman & Co first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $334M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Brown Brothers Harriman & Co held 191,956 shares of Thermo Fisher Scientific worth $96.2M as of Q2 2026.
- Brown Brothers Harriman & Co sold 146,663 Thermo Fisher Scientific shares in Q2 2026, an estimated $70.4M.
- Thermo Fisher Scientific made up 0.42% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #47 holding.
- Brown Brothers Harriman & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Brown Brothers Harriman & Co's Thermo Fisher Scientific position peaked at $334M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.